Search filters

List of works by Philippe Billiald

A method to confer Protein L binding ability to any antibody fragment

scientific article published on 18 December 2015

A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector.

scientific article

Antibody Fragments Humanization: Beginning with the End in Mind

scientific article published on 01 January 2019

Approach to the direct intramolecular localization of antigenic determinants in Androctonus australis hemocyanin with monoclonal antibodies by molecular immunoelectron microscopy.

scientific article published in September 1985

Biomolecular engineering of antidehydroepiandrosterone antibodies: a new perspective in cancer diagnosis and treatment using single-chain antibody variable fragment

scientific article published on 29 January 2019

Colorimetric engineered immunoprobe for the detection and quantification of microcystins.

scientific article

Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.

scientific article published in February 2001

Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies.

scientific article published on 16 May 2013

Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin.

scientific article

Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro

scientific article published on 25 June 2009

Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential

scientific article published on 02 July 2011

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

scientific article

Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

scientific article published on 28 February 2012

Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential

scientific article

Envenomations VI. Scorpionism in Africa

scientific article published on October 2007

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

scientific article published on 23 March 2016

Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.

scientific article

Grafting of protein L-binding activity onto recombinant antibody fragments

scientific article

Immunodetection of the "brown" spider (Loxosceles intermedia) dermonecrotoxin with an scFv-alkaline phosphatase fusion protein

scientific article

Immunolabeling of CD3-positive lymphocytes with a recombinant single-chain antibody/alkaline phosphatase conjugate.

scientific article

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential

scientific article published on 16 April 2020

Mapping of six epitopes on haemocyanin subunit Aa 6 by immunoelectron microscopy

scientific article published on 01 August 1988

Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI

scientific article published on 18 May 2009

PCR: principles and prospects in clinical biology

scientific article published in January 1995

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation

scientific article published on 04 June 2020

Production and characterization of a bivalent single chain Fv/alkaline phosphatase conjugate specific for the hemocyanin of the scorpion Androctonus australis ⬇️

scientific article published on October 23, 1998

Production of a functional anti-scorpion hemocyanin scFv in Escherichia coli

scientific article published on 01 March 1995

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development.

scientific article

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

scientific article published on 01 May 2019

The future of glycoprotein VI as an antithrombotic target.

scientific article published on December 2012

Using a recombinant bispecific antibody to block Na+ -channel toxins protects against experimental scorpion envenoming.

scientific article published on January 2007

[Antithrombotic recombinant antibodies]

scientific article published on 01 January 2006

[Recombinant antibodies: towards a new generation of antivenoms?]

scientific article published on 01 January 2006

Paulina is supported by:

About Paulina

Help